Company Description
COPRF (OTC: COPRF) is a publicly traded diagnostics & research company in the Healthcare sector. The company has a market capitalization of $4.4M.
COPRF stock has declined 76.3% over the past year.
This page provides a comprehensive overview of COPRF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
COPRF (COPRF) stock. Over the past 12 months, the stock has lost 76.3%. At a market capitalization of $4.4M, COPRF is classified as a micro-cap stock with approximately 405.3M shares outstanding.
Latest News
COPRF has 10 recent news articles. Key topics include earnings, covid-19, acquisition. View all COPRF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
COPRF Company Profile & Sector Positioning
COPRF (COPRF) operates in the Diagnostics & Research industry within the broader Healthcare sector.
Investors comparing COPRF often look at related companies in the same sector, including Check Cap (CHEK), Endra Life Sciences Inc (NDRA), XWELL Inc (XWEL), Applied Dna Scie (APDN), and Mainz Biomed NV (MYNZ). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate COPRF's relative position within its industry.